Are Fat Dissolving Injections Safe?

Yes — fat dissolving injections are safe when administered by a qualified medical professional using a regulated product. The active ingredient, deoxycholic acid, has an established clinical track record and has been studied in thousands of patients across multiple peer-reviewed trials.

Like all injectable treatments, the safety profile is closely tied to who performs the treatment and how. This article covers what the evidence shows, what side effects to expect, when fat dissolving is not appropriate, and what separates a safe treatment from a risky one.

At Dr Hass Clinic, we use Aqualyx — a CE-marked injectable solution whose active ingredient is deoxycholic acid. This is a bile acid produced naturally by the body to help break down dietary fats in the digestive system. When injected into a localised fat deposit, it disrupts the membrane of fat cells, causing them to break down. The body then clears the debris through the lymphatic system over the following weeks.

Because deoxycholic acid is rapidly inactivated on contact with surrounding tissue protein, its action stays spatially contained. It does not migrate freely through the body — a key part of why its safety profile is well-established.

It is worth distinguishing Aqualyx from unregulated alternatives such as Lemon Bottle, which lack comparable clinical evidence and regulatory oversight. Not all fat dissolving products carry the same safety record.

Deoxycholic acid is one of the better-studied injectable compounds in aesthetic medicine. The evidence covers both efficacy and safety, with consistent findings across different study designs and patient populations.

A systematic review and meta-analysis published in the Expert Review of Clinical Pharmacology (Cunha et al., 2021), incorporating data from five randomised controlled trials and 1,838 participants, found that deoxycholic acid produced statistically significant improvements across all efficacy measures compared to placebo. Withdrawal rates due to adverse events were low at the standard dose, and the authors reported no clinically significant changes in liver or kidney function.

A separate systematic review published in Dermatologic Surgery (Pham et al., 2020), which analysed 28 published studies on the adverse event profile of deoxycholic acid, concluded that the large majority of patients experienced only mild, localised side effects that resolved on their own. Severe long-term adverse events were reported as rare across the evaluated literature.

Together, this research supports fat dissolving as a safe treatment for localised fat reduction when correctly administered — not a claim of zero risk, but a treatment with a well-characterised and manageable safety profile.

Side effects after fat dissolving are normal, predictable, and in the vast majority of cases resolve without intervention. They are a direct consequence of the inflammatory process that breaks down fat cells — in other words, they are signs the treatment is working.

• Swelling — the most significant side effect, peaking at 24 to 72 hours and settling within 1 to 2 weeks
• Tenderness and sensitivity — typically subsides within a few days
• Bruising — may appear from day 2 and fades over 5 to 10 days
• Redness and warmth — a normal inflammatory response, usually resolves within 24 to 48 hours
• Firmness or lumpiness under the skin — temporary, resolves as healing progresses within 2 to 4 weeks
• Numbness — experienced by some patients, typically transient

For a detailed breakdown of what to expect day by day, see our fat dissolving recovery and aftercare guide.

Serious complications from fat dissolving are uncommon, but understanding them is part of making an informed decision.

• Nerve injury — the marginal mandibular nerve is a documented risk when treating the chin and lower face. In clinical trials, temporary muscle weakness was reported in a small number of patients and resolved without lasting effects in all cases. The risk is significantly reduced when treatment is performed by an anatomy-trained medical professional.
• Infection — a small risk with any injectable treatment. Strict aseptic technique and proper patient selection make this rare.
• Skin necrosis — very rare, and typically associated with incorrect injection depth or compromised blood supply in the treated area.
• Alopecia — reported in a small number of cases in the literature, predominantly where injections were performed near the scalp.
• Allergic reaction — uncommon but possible, as with any injectable substance.

The common thread across serious complications is that most are associated with incorrect technique, inappropriate patient selection, or unregulated products administered by insufficiently trained practitioners. They are not an inevitable feature of the treatment.

A thorough consultation and medical history review must always take place before treatment. Fat dissolving is not recommended for people who:

• Are pregnant or breastfeeding
• Have active skin infections or inflammation in the treatment area
• Have lipodystrophy or conditions affecting how the body processes fat
• Are significantly overweight — this is a contouring treatment, not a weight loss solution
• Have poor skin laxity in the treatment area — removing volume without sufficient elasticity can lead to sagging
• Are taking blood thinners or have clotting disorders
• Have a known allergy to any component of the product

Identifying these contraindications is one of the primary purposes of the consultation. Skipping this step is a clear sign of a clinic operating below appropriate standards.

The single most important safety factor is the person performing the treatment. The risks associated with nerve injury, skin necrosis, and incorrect injection depth are predominantly technique-dependent. They are not an inherent risk of the active ingredient — they are a consequence of inadequate training or experience.

Understanding the anatomy of a treatment area — the depth of fat deposits, proximity to nerves, vascular structures — is not something that comes from a short training course. It comes from a medical background in which anatomy is foundational.

At Dr Hass Clinic, all fat dissolving treatments are performed by GMC-registered doctors with a surgical background. Fat dissolving is increasingly offered in the UK by practitioners without medical qualifications. This is where the real risk in the market lies. The treatment itself is well-evidenced and safe; unqualified delivery is not.

Before proceeding with fat dissolving at any clinic, it is reasonable to ask:

• What product are you using and is it CE-marked?
• What are your medical qualifications?
• How many fat dissolving treatments have you performed?
• What would you do if I experienced a complication?
• Is a medical professional available if something goes wrong?

A reputable clinic will answer all of these clearly and without hesitation. If answers are vague or defensive, that is important information.

At Dr Hass Clinic, fat dissolving is performed by Dr Hasaneen — a GMC-registered surgeon with extensive experience in facial and body anatomy. Every patient undergoes a thorough consultation before treatment, during which suitability is assessed, contraindications are checked, and a realistic treatment plan is discussed. We use Aqualyx exclusively, and we do not offer unregulated fat dissolving products.

Our approach is built on the principle that the quality of care matters as much as the quality of the product. If fat dissolving is not the right treatment for you, we will tell you — and recommend what is.